Literature DB >> 21704667

Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.

Jane W Marsh1, Kathleen A Shutt, Rolando Pajon, Mary M Tulenko, Stephen Liu, Rosemary A Hollick, Julia A Kiehlbauch, Thomas A Clark, David S Stephens, Kathryn E Arnold, Robert A Myers, Leonard W Mayer, Lee H Harrison.   

Abstract

Several meningococcal vaccines under development for prevention of serogroup B disease target the factor H-binding protein (FHbp), an immunogenic lipoprotein expressed on the surface of Neisseria meningitidis. Based upon sequence and phylogenetic analyses, FHbp can be classified into 3 protein variants (1, 2 or 3) or 2 subfamilies (A or B). The potential effect of FHbp-containing vaccines on meningococcal carriage is not known. We determined the diversity of FHbp among a population of carriage isolates obtained from Georgia and Maryland high school students in 1998 and 2006-2007. Analysis of the fHbp gene sequence from 408 carriage isolates identified 30 different FHbp protein sequences. The majority of carriage isolates harbored FHbp proteins belonging to variant 2/subfamily A. Association between FHbp proteins and genetic lineage was observed among the carriage isolates. However, split decomposition analysis, together with tests of linkage disequilibrium and pairwise homoplasy suggest recombination at fHbp contribute to allelic diversity. Of note, the FHbp proteins in serogroup B vaccines under development are either absent or not well represented in this carriage population. The FHbp genetic repertoire observed in carriage isolate populations will be useful in understanding the potential impact of FHbp-containing vaccines on meningococcal carriage.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704667      PMCID: PMC4762365          DOI: 10.1016/j.vaccine.2011.06.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  40 in total

1.  Estimating diversifying selection and functional constraint in the presence of recombination.

Authors:  Daniel J Wilson; Gilean McVean
Journal:  Genetics       Date:  2005-12-30       Impact factor: 4.562

2.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

3.  Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.

Authors:  Stefania Bambini; Alessandro Muzzi; Per Olcen; Rino Rappuoli; Mariagrazia Pizza; Maurizio Comanducci
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

4.  Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.

Authors:  Han-Qing Jiang; Susan K Hoiseth; Shannon L Harris; Lisa K McNeil; Duzhang Zhu; Cuiwen Tan; Adrienne A Scott; Kristin Alexander; Kathryn Mason; Lynn Miller; Ida DaSilva; Michelle Mack; Xiao-Juan Zhao; Michael W Pride; Lubomira Andrew; Ellen Murphy; Michael Hagen; Roger French; Ashoni Arora; Thomas R Jones; Kathrin U Jansen; Gary W Zlotnick; Annaliesa S Anderson
Journal:  Vaccine       Date:  2010-07-07       Impact factor: 3.641

5.  Antigenic shift and increased incidence of meningococcal disease.

Authors:  Lee H Harrison; Keith A Jolley; Kathleen A Shutt; Jane W Marsh; Mary O'Leary; Laurie Thomson Sanza; Martin C J Maiden
Journal:  J Infect Dis       Date:  2006-03-28       Impact factor: 5.226

6.  Active bacterial core surveillance of the emerging infections program network.

Authors:  A Schuchat; T Hilger; E Zell; M M Farley; A Reingold; L Harrison; L Lefkowitz; R Danila; K Stefonek; N Barrett; D Morse; R Pinner
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

7.  Genetic basis for nongroupable Neisseria meningitidis.

Authors:  Jennifer M Dolan-Livengood; Yoon K Miller; Larry E Martin; Rachel Urwin; David S Stephens
Journal:  J Infect Dis       Date:  2003-04-30       Impact factor: 5.226

8.  The modular architecture of meningococcal factor H-binding protein.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Microbiology (Reading)       Date:  2009-07-02       Impact factor: 2.777

9.  Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis.

Authors:  Elizabeth A Mothershed; Claudio T Sacchi; Anne M Whitney; Gwen A Barnett; Gloria W Ajello; Susanna Schmink; Leonard W Mayer; Maureen Phelan; Thomas H Taylor; Scott A Bernhardt; Nancy E Rosenstein; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Authors:  Leah D Fletcher; Liesel Bernfield; Vicki Barniak; John E Farley; Alan Howell; Melissa Knauf; Peggy Ooi; Robert P Smith; Paige Weise; Mike Wetherell; Xiaoling Xie; Robert Zagursky; Ying Zhang; Gary W Zlotnick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  10 in total

1.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

2.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

3.  An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands.

Authors:  Stefania Bambini; Jurgen Piet; Alessandro Muzzi; Wendy Keijzers; Sara Comandi; Lisa De Tora; Mariagrazia Pizza; Rino Rappuoli; Diederik van de Beek; Arie van der Ende; Maurizio Comanducci
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

Review 4.  Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.

Authors:  Lisa K McNeil; Robert J Zagursky; Shuo L Lin; Ellen Murphy; Gary W Zlotnick; Susan K Hoiseth; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

5.  Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines.

Authors:  Eduardo Rojas; Johanna Hoyos; Neil J Oldfield; Philip Lee; Mike Flint; C Hal Jones; Dlawer A A Ala'Aldeen; Kathrin U Jansen; Annaliesa S Anderson
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec.

Authors:  Rodica Gilca; Philippe De Wals; Sheila M Nolan; Nicholas Kitchin; Joseph J Eiden; Qin Jiang; C Hal Jones; Kathrin U Jansen; Annaliesa S Anderson; Louise Pedneault
Journal:  mSphere       Date:  2018-12-05       Impact factor: 4.389

7.  Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease.

Authors:  Marco Spinsanti; Tarcisio Brignoli; Margherita Bodini; Lucia Eleonora Fontana; Matteo De Chiara; Alessia Biolchi; Alessandro Muzzi; Vincenzo Scarlato; Isabel Delany
Journal:  PLoS Pathog       Date:  2021-03-26       Impact factor: 6.823

8.  Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.

Authors:  Annaliesa S Anderson; Li Hao; Qin Jiang; Shannon L Harris; Thomas R Jones; John L Perez; Laura York; Joseph Eiden; Kathrin U Jansen
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

9.  Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis.

Authors:  Ludovic Lemée; Eva Hong; Manuel Etienne; Ala-Eddine Deghmane; Valérie Delbos; Aude Terrade; Gilles Berthelot; Francois Caron; Muhamed-Kheir Taha
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

10.  Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab.

Authors:  Deirdre Nolfi-Donegan; Monica Konar; Vianca Vianzon; Jessica MacNeil; James Cooper; Perrianne Lurie; Judi Sedivy; Xin Wang; Dan M Granoff; Lucy McNamara
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.